Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer ; volume:29 ; number:03 ; year:2008 ; pages:7-10
Indian journal of medical & paediatric oncology ; 29, Heft 03 (2008), 7-10
- Contributor
-
Ghosh, Jaya
Kumar, Lalit
- DOI
-
10.4103/0971-5851.51414
- URN
-
urn:nbn:de:101:1-2022042810022210418278
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ghosh, Jaya
- Kumar, Lalit
Other Objects (12)
Surgery for Recurrent Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Bevacizumab for patients with recurrent multifocal glioblastomas
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study
Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends
Surgery in recurrent ovarian cancer
Surgery for Recurrent Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Bevacizumab for patients with recurrent multifocal glioblastomas
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study
Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends
Surgery in recurrent ovarian cancer
Surgery for Recurrent Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Bevacizumab for patients with recurrent multifocal glioblastomas
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study
Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends